Saturday, October 6, 2018
CNLS officials visits Cameroon Link
By James Achanyi-Fontem, camlinknews
A delegation of three officials of the Littoral Technical Group visited the office of Cameroon Link on the 2nd October 2018 to evaluate the site for take off of dispensation of anti-retroviral drug in the community. The visit was a follow up of the protocol convention signed between the Technical Group of CNLS in the Littoral and Cameroon Link on 16 July 2018. Dr. YONGUI NTAMACK, Regional Coordinator, endorsed the protocol agreement on behalf of CNLS/GTR-Lt and James ACHANYI-FONTEM, President of Cameroon Link signed on behalf of the Civil Society Organisation.
This protocol falls within the frame work of a World Bank subvention for the fight against AIDS, Tuberculosis and Malaria in Cameroon. The dispensation of anti-retroviral drugs within the community by a non-medical structure by a staff living within the community is to facilitate access to treatment by patients and the Cameroon Link is now charged with undertaking the following activities:
- Explaining the the population what dispensation fo anti-retroviral therapies with the community entails, who can benefit i from the service, the advantages of dispensation of anti-retroviral drugs within the community, in which case should the patient return to the health facility, what are the services to be offered by Cameroon Link, counseling and organization of educative talks with the community.
- In effect any person that has been diagnosed can benefit from the services at Cameroon Link Support groups of persons living with HIV, well structured community therapy groups constituted within the community are eligible.
- These groups will benefit from the renewal of their prescription, biological follow-up, coaching on poor hygienic and sanitation.
- HIV patients will benefit from cordial attention, availibity of Cameroon Link staff, confidentiality and the reduction of delays for reception of and answers to the queries of patients.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment